受强制性开放获取政策约束的文章 - Aruna Korlimarla了解详情
可在其他位置公开访问的文章：10 篇
A majority of low (1-10%) ER positive breast cancers behave like hormone receptor negative tumors
JS Prabhu, A Korlimarla, K Desai, A Alexander, R Raghavan, ...
Journal of Cancer 5 (2), 156, 2014
强制性开放获取政策： Fonds de recherche du Québec - Santé
High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers
K Desai, MG Nair, JS Prabhu, A Vinod, A Korlimarla, S Rajarajan, ...
Cancer medicine 5 (8), 2000-2011, 2016
强制性开放获取政策： Department of Biotechnology, India
miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
MG Nair, JS Prabhu, A Korlimarla, S Rajarajan, H PS, R Kaul, ...
Cancer Medicine 9 (15), 5587-5597, 2020
强制性开放获取政策： Department of Biotechnology, India
HR+ HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells
K Desai, R Aiyappa, JS Prabhu, MG Nair, PV Lawrence, A Korlimarla, ...
Tumor Biology 39 (3), 1010428317695028, 2017
强制性开放获取政策： Department of Biotechnology, India
Pre-menopausal women with breast cancers having high AR/ER ratios in the context of higher circulating testosterone tend to have poorer outcomes
S Rajarajan, A Korlimarla, A Alexander, CE Anupama, R Ramesh, ...
Frontiers in Endocrinology 12, 679756, 2021
强制性开放获取政策： Wellcome Trust/DBT India Alliance, Wellcome Trust
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers
A Korlimarla, PS Hari, J Prabhu, C Ragulan, Y Patil, VP Snijesh, K Desai, ...
Translational Oncology 25, 101511, 2022
强制性开放获取政策： Cancer Research UK, UK Research & Innovation
Abstract PS6-55: The prognostic utility of AR/ER ratio in young women with breast cancer
JS Prabhu, A Korlimarla, S Rajarajan, A Alexander, C Anupama, ...
Cancer research 81 (4 Suppl), PS6-55, 2021
强制性开放获取政策： Wellcome Trust/DBT India Alliance
A comprehensive analysis of immune landscape of Indian triple negative breast cancer
A Korlimarla, PS Hari, J Prabhu, C Ragulan, Y Patil, VP Snijesh, K Desai, ...
bioRxiv, 2022.03. 06.483159, 2022
强制性开放获取政策： UK Research & Innovation
NGS-based profiling of key cancer genes in Indian triple-negative breast cancer patients reinforces molecular heterogeneity of the disease
NA Sahasrabuddhe, A Korlimarla, M Kulkarni, V Kusuma, JS Prabhu, ...
Indian Journal of Cancer 58 (4), 598-602, 2021
强制性开放获取政策： Department of Biotechnology, India
Examination of the role of integrin β3 in chemoresistance by analysis of residual NACT tumor specimens and knock-in experiments
MG Nair, JS Prabhu, J Remacle, S HP, A Korlimarla, RS Kaluve, ...
Annals of Oncology 28, i16, 2017
强制性开放获取政策： Department of Biotechnology, India
出版信息和资助信息由计算机程序自动确定